Ferdinand Groenewald - 18 Aug 2025 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)

Role
Vice President of Finance
Signature
/s/ Ferdinand Groenewald
Issuer symbol
TCRT
Transactions as of
18 Aug 2025
Net transactions value
$0
Form type
4
Filing time
20 Aug 2025, 19:54:48 UTC
Previous filing
02 Jun 2025
Next filing
21 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Groenewald Ferdinand Vice President of Finance C/O ALAUNOS THERAPEUTICS, INC., 501 E. LAS OLAS BLVD., SUITE 300, FORT LAUDERDALE /s/ Ferdinand Groenewald 20 Aug 2025 0001734018

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCRT Common Stock Award $0 +10,775 $0.000000 10,775 18 Aug 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRT Employee Stock Option (right to buy) Award $0 +4,000 $0.000000 4,000 18 Aug 2025 Common Stock 4,000 $2.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-sixteenth of the shares underlying the option vest in equal quarterly installments measured from August 18, 2025, with the first vesting occurring on November 18, 2025 subject to the Reporting Person's continued service through each vesting date.